(NASDAQ: PRQR) Proqr Therapeutics Nv's forecast annual revenue growth rate of -9.02% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Proqr Therapeutics Nv's revenue in 2025 is $19,930,232.On average, 4 Wall Street analysts forecast PRQR's revenue for 2025 to be $2,203,442,209, with the lowest PRQR revenue forecast at $1,045,872,994, and the highest PRQR revenue forecast at $3,685,867,546. On average, 3 Wall Street analysts forecast PRQR's revenue for 2026 to be $1,883,109,944, with the lowest PRQR revenue forecast at $1,023,253,702, and the highest PRQR revenue forecast at $2,407,338,973.
In 2027, PRQR is forecast to generate $1,633,974,596 in revenue, with the lowest revenue forecast at $1,027,562,139 and the highest revenue forecast at $2,240,387,053.